The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines
Abstract
Significance: Here we report that addiction to histone lysine demethylase (KDM)6B expression is shared by a number of cervical carcinoma lines and arises as a direct and immediate consequence of human papillomavirus (HPV)16 E7 oncoprotein expression. We also report that the p16 INK4A tumor suppressor is a mediator of KDM6B addiction and that p16 expression is necessary for survival of HPV E7-expressing cells. The addiction of p16 INK4A is based on its ability to inhibit CDK4/CDK6 activity. We also present data that KDM6 inhibition may be evaluated as a therapeutic modality for high-risk HPV-associated lesions and cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“KDM6B induction mediates increased expression of the cervical cancer biomarker p16INK4A. Higher expression of p16INK4A caused by HPV-16 E7 mediated KDM6D upregulation represents an E7-triggered oncogene-induced senescence (OIS) response.”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [333]
In the citing paper
“HPVs have evolved to target pRB for ubiquitin-dependent proteasomal degradation, which is why p16INK4A upregulation in HPV-positive cancer cells does not inhibit proliferation [332,333,334]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
De Santa, F., Totaro, M. G., Prosperini, E., Notarbartolo, S., Testa, G., & Natoli, G. (2007) · Cell · doi:10.1016/j.cell.2007.08.019 · Cited by 965
Lund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489
Agger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez-Niedenführ, M., Maertens, G., Banck, M., Zhou, M.-M., Walsh, M. J., et al. (2009) · Genes & Development · doi:10.1101/gad.511109 · Cited by 352
Epigenetic regulation of the INK4b-ARF-INK4a locus: In sickness and in health
Popov, N., & Gil, J. (2010) · Epigenetics · doi:10.4161/epi.5.8.12996 · Cited by 202
Research works printed but not linked: 38
- 10.1038/nrg1981 · DOI · Paper page
- 10.1038/ng1792 · DOI
- 10.1126/science.1084274 · DOI
- 10.1242/dev.033902 · DOI
- 10.1038/nature06145 · DOI
- 10.1038/nature06270 · DOI
- 10.1038/nature06192 · DOI
- 10.1126/science.1149042 · DOI
- 10.1073/pnas.1009933108 · DOI · Paper page
- 10.1128/JVI.75.16.7583-7591.2001 · DOI · Paper page
- 10.1016/0092-8674(90)90409-8 · DOI · Paper page
- 10.1001/archotol.130.1.68 · DOI
- 10.1126/science.7652577 · DOI
- 10.4161/cc.22589 · DOI
- 10.1016/S0304-3835(02)00282-3 · DOI
- 10.1074/jbc.M112.424903 · DOI
- 10.1038/sj.onc.1204850 · DOI
- 10.1128/JVI.00160-11 · DOI
- 10.1158/0008-5472.CAN-07-2056 · DOI
- 10.1158/0008-5472.CAN-05-4470 · DOI
- MF De Souza Setubal Destro, et al., Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis. Int J Oncol 36, 141–149 (2010).
- 10.1158/0008-5472.CAN-07-2926 · DOI
- 10.1056/NEJMoa1110000 · DOI
- 10.1016/S0002-9440(10)65689-1 · DOI
- 10.1016/j.ccr.2011.10.001 · DOI · Paper page
- 10.4161/cc.4.1.1366 · DOI
- 10.1038/nature02650 · DOI
- 10.1002/jcp.10286 · DOI
- 10.1186/bcr2142 · DOI
- S Kommoss, et al., Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: A translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Br J Cancer; AGO-OVAR 96, 306–313 (2007). · DOI
- 10.1016/j.lungcan.2009.03.018 · DOI
- 10.1097/00004347-200304000-00009 · DOI
- 10.1038/35106065 · DOI
- 10.1073/pnas.1119836109 · DOI
- 10.1073/pnas.0711865105 · DOI
- 10.1073/pnas.0813139106 · DOI
- 10.1038/nsmb.1499 · DOI
- 10.1128/jvi.65.1.473-478.1991 · DOI · Paper page
Cited by
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer
Zhao, R., Choi, B. Y., Lee, M.-H., Bode, A. M., & Dong, Z. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.017 · Cited by 425
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- McLaughlin-Drubin, M. E., Park, D., & Munger, K.
- Affiliations
- Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA 02115; and
- Committee on Virology,
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-09-17
- Volume
- 110
- Issue
- 40
- Pages
- 16175-16180
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 163
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
